Status:
COMPLETED
Alcohol & Metabolic Comorbidities in PLWHA: Evidence Driven Interventions
Lead Sponsor:
Louisiana State University Health Sciences Center in New Orleans
Conditions:
HIV/AIDS
Dysglycemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cross-sectional and prospective studies are proposed to test the prediction that a higher proportion of HIV+ individuals with hazardous alcohol drinking with subclinical fasting dysglycemia will prese...
Detailed Description
Adult male and female in care PLWHA with fasting plasma glucose (FPG) \>94 mg/dL and \<125 mg/dL will be recruited. Measures of FPG and HbA1c obtained from overnight fasted subjects. Alcohol use disor...
Eligibility Criteria
Inclusion
- HIV positive
- Fasting glucose above 94 mg/dL and below 125 mg/dl
- Without diagnosis of diabetes mellitus
- "No" response to six questions in Physical Activity Readiness Questionnaire (PAR-Q), given at time of screening
Exclusion
- Lack of informed consent
- Decisionally impaired individuals
- Non-English speaking
- Acute illness within the preceding six weeks (defined as fever, new antibiotic use or unscheduled healthcare visit (for illness))
- Acute alcohol intoxication
- Pregnancy
- Currently prescribed blood thinners (if undergoing muscle biopsy)
- Allergy to Lidocaine (if undergoing muscle biopsy)
- Significant peripheral neuropathies (if undergoing exercise)
- Significant cardiovascular impairments (if undergoing exercise)
Key Trial Info
Start Date :
November 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2023
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT03299205
Start Date
November 20 2017
End Date
September 15 2023
Last Update
October 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Louisiana State University Health Sciences Center
New Orleans, Louisiana, United States, 70112